The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


40 Mg/Ml Concentrate and solvent for solution for infusion

Teva B.V.EU/1/09/611/1-2

Main Information

Active SubstancesDOCETAXEL
Strength40 Mg/Ml
Dosage FormConcentrate and solvent for solution for infusion
Licence HolderTeva B.V.
Licence NumberEU/1/09/611/1-2

Group Information

ATC CodeL01CD02 docetaxel


Licence Issued26/01/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back